BiotechTube
Home/reMYND/Katrien Princen, PhD
KP

Katrien Princen, PhD

Head of Operations

reMYND

Therapeutic Areas

Alzheimer's DiseaseHuntington's DiseaseAmyotrophic Lateral Sclerosis (ALS)

reMYND Pipeline

DrugIndicationPhase
REM392 (Alzheimer's Program)Alzheimer's DiseasePre-clinical
Huntington's ProgramHuntington's DiseasePre-clinical
Discovery ProgramAmyotrophic Lateral Sclerosis (ALS)Discovery

Leadership Team at reMYND

FS
Floor Stam, PhD
CEO
GG
Gerard Griffioen, PhD
CSO
CF
Chris Freitag, MD
Clinical Advisor
NV
Nancy Van Osselaer, PhD
Development Advisor
SL
Sara Lambrechts
Head of Finance
View full reMYND profile